Johnson & Johnson sues Biden administration over Medicare drug price negotiations

Johnson & Johnson connected Tuesday sued the Biden medication implicit Medicare's caller powers to slash cause prices, making it the 3rd pharmaceutical institution to situation the arguable proviso of the Inflation Reduction Act.  

The suit filed successful national territory tribunal successful New Jersey argues the Medicare negotiations interruption the First and Fifth Amendments of the U.S. Constitution. Earlier suits brought separately by Merck and Bristol Myers Squibb, arsenic good arsenic by the U.S. Chamber of Commerce and PhRMA, the pharmaceutical industry's largest lobbying group, made akin arguments.

J&J said its suit aims to halt the "innovation-damaging legislature overreach that threatens the United States' primacy successful processing transformative therapies and successful patients' entree to those treatments."

The argumentation aims to marque drugs much affordable for older Americans but volition apt trim pharmaceutical manufacture profits. 

The Health and Human Services Department, which is named arsenic the suspect successful the lawsuits, did not instantly respond to CNBC's petition for comment. 

This communicative is developing. Please cheque backmost for updates.